Skip to content
Menu Open
Menu Close
Contact Us
Login
Haemoglobin Laboratory Solutions
Premier Hb9210™ HbA1c Analyser
Premier Resolution
Find a Haemoglobin Laboratory Product
Laboratory Diagnostics
Find a Laboratory Diagnostic Product
Rapid HIV Tests
UniGold (HIV)
TrinScreen (HIV)
Find a Rapid HIV Test
Immco Reference Lab
Search all Products
Find a Diagnostic Product
In Development
Continuous Glucose Monitoring
PrePsia™ Preeclampsia test
epiCapture Prostate Cancer Test
Investor Relations
Overview
Board of Directors
Financial Reports & Notices
Press Releases
Investor Contact
SEC Filing
About us
Our Company
Contact Us
Press Releases
June 16, 2026
Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results
May 1, 2026
Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations
March 23, 2026
Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test
March 18, 2026
Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren’s Syndrome
March 12, 2026
Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next Generation Premier Hb9210 HbA1c Column System
March 11, 2026
Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program
March 10, 2026
Trinity Biotech Provides Business and Trading Update
March 10, 2026
Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform
February 25, 2026
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
February 20, 2026
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares
February 18, 2026
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement
February 10, 2026
Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation
February 10, 2026
Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026
December 23, 2025
Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives
December 23, 2025
Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests
December 15, 2025
Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution
November 18, 2025
Trinity Biotech Secures Regulatory Approval for Offshored and Outsourced Manufacturing of Uni-Gold Rapid HIV Test
November 14, 2025
Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test
September 2, 2025
Trinity Biotech Regains NASDAQ Compliance
August 22, 2025
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
Load More
View All
